wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q30371972-FE88A3EF-C1A5-4378-AC74-DA1E49EDD591
Q30371972-FE88A3EF-C1A5-4378-AC74-DA1E49EDD591
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30371972-FE88A3EF-C1A5-4378-AC74-DA1E49EDD591
Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement
P2860
Q30371972-FE88A3EF-C1A5-4378-AC74-DA1E49EDD591
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30371972-FE88A3EF-C1A5-4378-AC74-DA1E49EDD591
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a42e9d549fbe0cfc240d663ecaefbb0b6df7ad2
P2860
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.